Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
HR Shared Services Trends Report 2026
The world of HR is evolving rapidly, as organisations look to improve efficiency, embrace AI and enhance the employee experience. This report by LACE Partners looks into how organisations can balance artificial intel...
BLOG | Human Capital at the Crossroad
Artificial intelligence, geopolitical instability and sustained economic uncertainty are reshaping the human capital agenda and placing new demands on Boards. Workforce models, skills requirements, talent strategies ...
Leadership in Times of Radical Change
There are significant changes underway in the UK’s water industry. Phil Aspin, CFO of United Utilities, talks to Criticaleye about adaptability, investment and his own personal journey as a finance leader. A...
Displaying 1 to 3 of 208
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
